Correction: Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis.

Correction: Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis.

Bibliographic Details
Main Authors:	Qing-ping Wang, Xiao-zhi Cao, Xue-dong Wang, Juan Gu, Li-min Wen, Li-ming Mao, Ping-nan Shan, Ai-guo Tang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3637461

Similar Items

Utility of NT-proBNP for identifying LV failure in patients with acute exacerbation of chronic bronchitis.
by: Qing-ping Wang, et al.
Published: (2013-01-01)

Correction: Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis
Published: (2013-01-01)

The integration of BNP and NT-proBNP into clinical medicine
by: Swiss Medical Weekly
Published: (2007-01-01)

The Potential Role of Salivary NT-proBNP in Heart Failure
by: Aidonis Rammos, et al.
Published: (2023-08-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

Using NT-proBNP as a criterion for heart failure hospitalization
by: Babak Tamizifar, et al.
Published: (2012-01-01)

NT-proBNP and Echocardiographic Parameters in Patients with Acute Heart Failure
by: Radek Pudil, et al.
Published: (2007-01-01)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
by: Hussein Alawieh, et al.
Published: (2019-11-01)

Sendaway capillary NT-proBNP in pulmonary hypertension
by: Eleanor Morris, et al.
Published: (2024-03-01)

The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01)

NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
by: Paweł Komarnicki, et al.
Published: (2023-09-01)

Prognostic Significance of First Week NT-ProBNP Levels in Heart Failure
by: SHOBHITENDU KABI, et al.
Published: (2018-09-01)

N-Terminal-proBNP [NT-proBNP], a surrogate biomarker of combined clinical and hemodynamic outcomes following PTMC
by: K.P. Ranganayakulu, et al.
Published: (2014-11-01)

Highly sensitive detection of NT-proBNP by molecular motor
by: Jie Zhang, et al.
Published: (2017-03-01)

Serum NT-ProBNP potential marker of cirrhotic cardiomyopathy
by: Maya Risteska, et al.
Published: (2022-10-01)

NT-proBNP and prognostics variables in acute myocardial infarction
by: Jorge Vendrell Cabrera, et al.
Published: (2012-01-01)

Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
by: Shoko Aoki, et al.
Published: (2023-02-01)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
by: Robert A. Lewis, et al.
Published: (2020-05-01)

Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry
by: Pankaj Garg, et al.
Published: (2022-06-01)

Association of E/E' and NT-proBNP with renal function in patients with essential hypertension.
by: Yan Yang, et al.
Published: (2013-01-01)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
by: Li H, et al.
Published: (2020-02-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)

Metformin therapy and circulating NT-proBNP levels: the CAMERA trial
by: Preiss, D, et al.
Published: (2016)

Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
by: Lise Legrand, et al.
Published: (2020-05-01)

LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
by: Maria António, et al.
Published: (2023-07-01)

SST2 and NT-proBNP biomarkers in prediction of COVID-19
by: O.O. Samchuk, et al.
Published: (2023-06-01)

NT-proBNP na estratificação de risco no tromboembolismo pulmonar
by: Hélder Dores, et al.
Published: (2011-12-01)

The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic
by: Lucian MURESAN, et al.
Published: (2017-06-01)

NT-proBNP in Myocarditis after a Scorpion Sting Envenomation
by: Suresh V Sagarad, et al.
Published: (2013-01-01)

Prognostic value of NT-proBNP in patients with severe COVID-19
by: Lei Gao, et al.
Published: (2020-04-01)

Função diastólica na estenose aórtica: correlação com NT-ProBNP e remodelamento pós-operatório Correlation to NT-ProBNP and remodeling after cardiac surgery
by: Berta Paula Napchan Boer, et al.
Published: (2013-05-01)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
by: Claire Sweeney, et al.
Published: (2021-12-01)

The combined role of NT-proBNP and LV-GLS in the detection of early subtle chemotherapy-induced cardiotoxicity in breast cancer female patients
by: Laila Sulaiman, et al.
Published: (2021-03-01)

The cost‐effectiveness of NT‐proBNP for assessment of suspected acute heart failure in the emergency department
by: Ryan Walkley, et al.
Published: (2023-12-01)

NT‐proBNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure
by: Isaac R. Whitman, et al.
Published: (2019-04-01)

Prognostic value of the combination of uric acid and NT-proBNP in patients with chronic heart failure
by: Gülsüm Meral Yılmaz Öztekin, et al.
Published: (2022-05-01)

Evaluation of NT-proBNP in children with heart failure younger than 3 years old
by: Iacob Daniela, et al.
Published: (2017-06-01)

Serum level of apelin-13 negatively correlated with NT-proBNP in heart failure patients
by: Goidescu Cerasela Mihaela, et al.
Published: (2016-12-01)

Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
by: Fouad Chouairi, BS, et al.
Published: (2021-04-01)

Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?
by: Tuba Cimilli Ozturk, et al.
Published: (2011-01-01)